


英文名 | TNIK-IN-3 | ||
级别 | For Signal Pathway Regulation | 相关类别 | 细胞骨架 |
储存 | 冷冻(-20℃) | 分子量 | 387.41 |
靶点 | Wnt/beta-catenin | ||
编 号 | 包装 | 库存 | 目录价(¥) | 您的价格(¥) | 数 量 |
A413657-0001 | 1 MG | 咨询 |
![]() |
![]() |
![]() |
A413657-0005 | 5 MG | 咨询 |
![]() |
![]() |
![]() |
A413657-0010 | 10 MG | 咨询 |
![]() |
![]() |
![]() |
A413657-0025 | 25 MG | 咨询 |
![]() |
![]() |
![]() |
A413657-0050 | 50 MG | 咨询 |
![]() |
![]() |
![]() |
A413657-0100 | 100 MG | 咨询 |
![]() |
![]() |
![]() |
概述
TNIK-IN-3 is a highly potent and orally active inhibitor of Traf2- and Nck-interacting protein kinase (TNIK). It exhibits a strong selectivity for TNIK with an IC50 value of 0.026 μM. Additionally, TNIK-IN-3 demonstrates inhibitory activity against Flt4 (IC50 = 0.030 μM), Flt1 (IC50 = 0.191 μM), and DRAK1 (IC50 = 0.411 μM). This compound holds potential for carrying out research on colorectal cancer (CRC) [1].
属性
保存温度&条件 | 粉末:-20°C,2年;在溶剂中:-80°C,1年 |
信号通路 | 细胞骨架|干细胞 |